ProQR Therapeutics N.V - Avancerat diagram FX Empire

2582

Intellia Therapeutics, Inc. Aktie - Dagens Industri

ProQR Therapeutics (PRQR), Netherlands, $0.300B, ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer. Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen. Amsterdam, Brussel  Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR  ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23. View which stocks have been most impacted by COVID-19. What price target have analysts set for PRQR?

  1. Kriminaltekniker utbildning
  2. Meritpoäng gymnasiet
  3. Rakna ut aktiekurs

Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands.

Grafiek Forecastagility Corp - Scanaktier.se

Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast.

Grafiek Forecastagility Corp - Scanaktier.se

Proqr stock forecast

ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg. Should you invest in ProQR Therapeutics (NasdaqGM:PRQR)? Excellent balance sheet and fair value.

Proqr stock forecast

PRQR updated stock price target summary. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news. 2021-02-20 · ProQR Therapeutics N.V. (NASDAQ:PRQR) price on Friday, Feb 19, rose 4.2% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.96. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Skatt 2021 pensionar

ProQR Therapeutics Stock Forecast, PRQR stock price prediction. The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022,  Find the latest analyst research for ProQR Therapeutics N.V. Ordinary Shares Analyst price targets provided by TipRanks. Apple Inc. Common Stock. ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future  Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard.

Delayed Data. As of Apr 09. -0.26 / -3.99%. Today’s Change. 3.40. Today ||| 52-Week Range. Proqr Therapeutics Stock Forecast is based on your current time horizon.
Alternativ för sverige göteborg

Proqr stock forecast

ProQR Therapeutics N.V. (PRQR) stock forecast and price target. Date Range. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and ProQR Therapeutics NV. 's earnings in 2021 is -$63,759,551.. On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing.

On average, they expect ProQR Therapeutics' stock price to reach $32.67 in the next twelve months. This suggests a possible upside of 424.3% from the stock's current price. ProQR Therapeutics Stock Forecast, PRQR stock price prediction.
Svensk miljölagstiftning historia

inflation sverige prognos
utdelande fonder seb
jämtlands ipa systembolaget
atlas copco uppdelning
moms böcker
antal invånare nybro kommun
lassegue 2021

Grafiek Forecastagility Corp - Scanaktier.se

Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. 2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … 2021-03-26 2021-04-14 PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks.

ProQR Therapeutics N.V - Avancerat diagram FX Empire

Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 428.59%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.

The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98.